A Case of Contrast-Induced Encephalopathy Using Iodixanol
|
|
- Ruth Black
- 6 years ago
- Views:
Transcription
1 540 J ENDOVASC THER CASE REPORT A Case of Contrast-Induced Encephalopathy Using Iodixanol Emiliano Chisci, MD, PhD; Francesco Setacci, MD; Gianmarco de Donato, MD; and Carlo Setacci, MD Department of Surgery, Vascular and Endovascular Surgery Unit, University of Siena, Italy. Purpose: To document a heretofore unreported complication of the contrast agent iodixanol during an endovascular procedure. Case Report: A 76-year-old woman with a history of coronary artery disease was admitted to the emergency department for recurrent transient ischemic attacks. Before combined percutaneous transluminal coronary angioplasty and carotid artery stenting (CAS) using iodixanol, the patient suffered from concomitant unstable angina and recurrent transient ischemic attacks. The total amount of iodixanol used during the CAS procedure was 300 ml. Contrast-induced encephalopathy, which manifested as aphasia, stupor, and full hemiparesis immediately after the combined procedure, was diagnosed by urgent computed tomography. Treatment was based on anti-edema drugs, and the patient made a complete recovery within 48 hours, without any neurological sequelae. Conclusion: Although previously reported in relation to other types of contrast media, contrast-induced encephalopathy has never been described as a complication of an endovascular procedure using iodixanol. J Endovasc Ther. Key words: contrast media, endovascular intervention, complication, contrast-induced encephalopathy, carotid artery stenting, percutaneous coronary intervention, concurrent procedures See Commentary page 545 Contrast-induced encephalopathy (CIE) has been described during various endovascular interventions, 1 10 and neurotoxicity is a wellknown adverse effect of contrast agents, which can cause osmotic disruption of the blood-brain barrier. 11 Symptoms include visual disturbances, transient cortical blindness, and transient neurological deficits Different contrast agents, both ionic and nonionic, were used in the cases reported in the literature, but they were all hyperosmolar in relation to blood The particularity of the case we report here is that CIE occurred despite the use of an isosmolar contrast agent (osmolality of 290 mosm/kg H 2 O, the same as blood); to our knowledge, no one has reported CIE in conjunction with the use of an isosmolar contrast agent. CASE REPORT A 76-year-old right-handed woman was admitted to our emergency department for recurrent transient ischemic attacks (TIA) causing transient aphasia, as well as right facial and brachial hemiparesis (lasting,24 hours) associated with intermittent chest pain The authors have no commercial, proprietary, or financial interest in any products or companies described in this article. Address for correspondence and reprints: Emiliano Chisci, Department of Surgery, Vascular and Endovascular Surgery Unit, University of Siena, Viale Bracci, Siena, Italy. e.chisci@gmail.com ß 2011 by the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS Available at
2 J ENDOVASC THER IODIXANOL COMPLICATION 541 while resting. The patient had suffered from unstable angina for nearly 1 month prior to admission and had been scheduled to have an elective coronary arteriogram a few days later. Physical examination did not show any obvious neurological deficit, and even the non-enhanced computed tomography (CT) scan did not show any recent cerebral ischemia. The electrocardiogram showed subendocardial ischemia, and troponin levels were abnormal (0.9 mg/dl). A color duplex ultrasound scan revealed an ostial, calcified, eccentric.80% stenosis in the left internal carotid artery. The patient had a medical history of coronary artery disease, coronary bypass grafting, hypertension, severe dyslipidemia (treated with statins), peripheral artery disease, slight decrease in renal function (estimated glomerular filtration rate 45 ml/min/1.73 m 2 ), and diabetes. A team of vascular surgeons, cardiologists, and neurologists discussed the case and planned a single-session percutaneous transluminal coronary angioplasty (PTCA) and carotid artery stenting (CAS) procedure. A loading dose of clopidogrel (300 mg) was administered, and aspirin was provided as part of the patient s chronic therapy. The planned intervention took place on the day after admission. Both procedures were performed through a transfemoral approach with an 8-F short introducer sheath placed into the common femoral artery. A full dose of heparin was given intravenously (5000 units), and the activated clotting time did not exceed 230 seconds during both procedures. During PTCA, multiple lesions at the level of the interventricular artery were treated with 3 bare balloon-expandable stents (Tsunami; Terumo, Tokyo, Japan); this procedure required nearly 200 ml of iodixanol (Visipaque 320 mg l/ml; GE Healthcare, Waukesha, WI, USA). In the subsequent CAS procedure, the left common carotid artery was engaged with a guiding catheter (40u Multipurpose; Boston Scientific, Natick, MA, USA), and extra- and intracranial angiography was performed. A distal embolic protection device (EPI Filter Wire EZ; Boston Scientific) was placed across the lesion, followed by atropine administration (0.5-mg intravenous bolus) and predilation of the ostial calcified.80% lesion with a cutting balloon ( mm; Boston Scientific). A 7330-mm closed-cell stent (Carotid Wallstent; Boston Scientific) was placed because of the symptomatic nature of the lesion. Postdilation was performed using a mm balloon at 8 atmospheres for 10 seconds under a second identical atropine bolus. The total amount of contrast agent used was nearly 300 ml of iodixanol. This procedure was also uneventful until the arterial closure device was being placed, when the patient manifested sudden stupor, aphasia, and full right hemiparesis. At this point, the guidewire was no longer in place, so a non-enhanced CT scan was performed, which showed left (ipsilateral) hemispheric contrast staining of the cerebral sulci and hyperdensity of some subarachnoid spaces due to extravasation of the contrast medium (Figure, A). The diagnosis was a massive left hemisphere CIE. Treatment consisted of intravenous mannitol (125 mg/l 3 3) and a 40-mg intravenous bolus of methylprednisolone on the first day; on the second day, the mannitol was reduced to 2 doses and the methylprednisolone bolus cut in half to 20 mg. On day 3, 1 dose of mannitol was given with a 10-mg bolus of methylprednisolone. Under this regimen, both the symptoms and contrast staining disappeared after 48 hours (Figure, B). The patient recovered uneventfully from the CIE, and neurological and psychometric tests were negative at 30 days and 1 year after the procedure. DISCUSSION Insofar as we can tell, this is only the third case of CIE after CAS, and neither of the previous cases involved iodixanol. Both were performed in patients suffering from TIAs 2,3 ; one underwent an isolated CAS procdure, 2 whereas the other had combined PTCA and CAS, 3 as in our case. Both of these cases recovered uneventfully from CIE within 2 to 4 days. Of note, one case was performed using an ionic low osmolar contrast agent (i.e., ioxaglate) 2 and the other using a nonionic low osmolar agent (i.e., iohexol). 3 The Table offers more details regarding these 2 cases. In cases of CIE reported by cardiologists or neuroradiologists following other endovascular
3 542 IODIXANOL COMPLICATION J ENDOVASC THER Figure (A) Non-enhanced computed tomography performed immediately after the combined PTCA + CAS procedure. There is left hemispheric contrast staining of the cortical sulci and hyperdensity of some subarachnoid spaces due to extravasation of the contrast agent. The good outcome and quick recovery of the patient is the key point to guide the clinician toward the diagnosis of contrast encephalopathy (CIE). Moreover, in the setting of CIE, another area of the brain may also be involved (e.g., posterior circulation), while in the case of hyperperfusion syndrome (the worst scenario is hemorrhage), the brain damage is exclusively limited to the territory of the treated internal carotid artery. (B) Normal nonenhanced computed tomography at 48 hours documenting complete clearing of the left hemispheric contrast staining. procedures (but not CAS), the contrast media were either ionic or nonionic agents. 1,4 10 To our knowledge, no cases of CIE associated with an isosmolar contrast agent such as iodixanol have been reported to date. This agent s osmolarity is identical to blood, which should reduce the risk of osmotic effects and thereafter complications. It may be speculated in this specific case that the large amount of contrast used (300 ml) and the presence of precedent TIAs could have predisposed the patient to CIE and allowed the contrast agent TABLE Details of the 2 Cases of Post-CAS Contrast Encephalopathy Reported Thus Far in the Literature Dangas et al. 2 Fang et al. 3 Preop Neurological Status Type of Contrast Procedure Symptomatic (TIAs), confusion, hemiparesis Symptomatic (TIAs), hemiparesis Ioxeglate (ionic low osmolar, 180 ml) Iomexol (nonionic low osmolar, 250 ml) Medical Treatment Outcome CAS ACT: 210 s NA Complete recovery within 2 days PTCA + CAS ACT: 144 s NA Complete recovery within 4 days TIA: transient ischemic attack, PTCA: percutaneous transluminal coronary angioplasty, CAS: carotid artery stenting, ACT: activated clotting time.
4 J ENDOVASC THER IODIXANOL COMPLICATION 543 to disrupt the blood-brain barrier and concentrate in the brain. 11 Of note, the systemic delivery of contrast medium during PTCA did not cause bilateral contrast encephalopathy or any symptoms; only when iodixanol was injected directly in the left internal carotid artery did symptoms appear. We can postulate that in this patient there was a threshold for contrast sensitivity, which was triggered by the iodixanol injected during CAS (after 200 ml during PTCA). This hypothesis is debatable, and any cause-effect relation has not yet been demonstrated. However, the etiology of this CAS complication has to be attributed to the contrast agent owing to (1) the rapid recovery from neurological deficits and (2) because symptoms disappeared completely when contrast staining of the cerebral sulci and hyperdensity of some subarachnoid spaces disappeared. When a contrast agent permeates part of the brain (an entire hemisphere in this patient), it can cause cortical dysfunction by increasing neuronal excitability. 9 Although the neuroradiological findings may be impressive (Figure, A), the prognosis of CIE is excellent, and a wait-and-see approach may even be appropriate if symptoms are limited, although the use of anti-edema drugs is nonetheless advisable. If neurological deterioration is significant, intubation and sedation have been used to protect the brain. 4 In any case, it is crucial to make a differential diagnosis among CIE and microembolic shower (general slowing of contrast media without evidence of focal filling defects at angiography and cerebral edema at CT), subarachnoid hemorrhage 12 (no rapid recovery from neurological deficits, without complete resolution of contrast staining on follow-up CT within hours), and hyperperfusion syndrome (diffuse cerebral edema and effacement of the cortical sulci at CT; brain damage is exclusively limited within the treated artery distribution brain territory), as they require different treatment. 1 Neuroradiological imaging is essential in order to make a differential diagnosis. Another point of discussion concerning our case is that concomitant coronary and carotid pathology is a very frequent situation (5% to 15%). 13 Unfortunately, there is so far no sufficient evidence to support one specific treatment strategy over others. In the meantime, the best revascularization strategy for patients with advanced coronary and carotid disease should be tailored on a case-by-case basis by a multidisciplinary team in highvolume centers. 13 Although CIE is a benign complication, and it seems that there is no increased risk during re-exposure, subsequent contrast studies in a patient with a previous CIE should be undertaken with caution. Conclusion This anecdotal case report shows that even iodixanol, an isosmolar contrast agent, can cause contrast-induced encephalopathy. CIE remains a rare and benign complication following endovascular procedures. Neuroradiological imaging is mandatory to make a differential diagnosis, especially to rule out other more threatening complications that require different treatment. REFERENCES 1. Nicosia A, Nikas D, Castriota F, et al. Classification for carotid artery stenting complications: manifestation, management, and prevention. J Endovasc Ther. 2010;17: Dangas G, Monsein LH, Laureno R, et al. Transient contrast encephalopathy after carotid artery stenting. J Endovasc Ther. 2001;8: Fang HY, Kuo YL, Wu CJ. Transient contrast encephalopathy after carotid artery stenting mimicking diffuse subarachnoid hemorrhage: a case report. Catheter Cardiovasc Interv. 2009;73: Guimaraens L, Vivas E, Fonnegra A, et al. Transient encephalopathy from angiographic contrast: a rare complication in neurointerventional procedures. Cardiovasc Intervent Radiol. 2010;33: Studdard WE, Davis DO, Young SE. Cortical blindness after cerebral angiography. J Neurosurg. 1981;54: Parry R, Rees JR, Wilde P. Transient cortical blindness after coronary angiography. Br Heart J. 1993;70: Kinn RM, Breisblatt WM. Cortical blindness after coronary angiography: a rare but reversible complication. Cathet Cardiovasc Diagn. 1991;22:
5 544 IODIXANOL COMPLICATION J ENDOVASC THER 8. Torvik A, Walday P. Neurotoxicity of watersoluble contrast media. Acta Radiologica. 1995; 399: Rama BN, Pagano TV, DelCore M, et al. Cortical blindness after cardiac catheterization: effect of rechallenge with dye. Cathet Cardiovasc Diagn. 1993;28: Sawaya RA, Hammoud R, Arnaout S, et al. Contrast-induced encephalopathy following coronary angioplasty with iohexol. South Med J. 2007;100: Muruve DA, Steinman TI. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency. Clin Nephrol. 1996;45: Sharp S, Stone J, Beach R. Contrast agent neurotoxicity presenting as subarachnoid hemorrhage. Neurology. 1999;52: Roffi M. Management of patients with concomitant severe coronary and carotid artery disease: is there a perfect solution? Circulation. 2007;116:
Case Report Contrast-Induced Neurotoxicity following Cardiac Catheterization
Case Reports in Medicine Volume 2012, Article ID 267860, 4 pages doi:10.1155/2012/267860 Case Report Contrast-Induced Neurotoxicity following Cardiac Catheterization Susan Law, 1, 2 Kessarin Panichpisal,
More informationEndovascular treatment for pseudoocclusion of the internal carotid artery
Endovascular treatment for pseudoocclusion of the internal carotid artery Daqiao Guo, Xiao Tang, Weiguo Fu Institute of Vascular Surgery, Fudan University, Department of Vascular Surgery, Zhongshan Hospital
More informationCAROTID ARTERY ANGIOPLASTY
CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationSubclavian artery Stenting
Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationExtracranial Carotid Artery Stenting With or Without Distal Protection Device
Extracranial Carotid Artery Stenting With or Without Distal Protection Device Eak-Kyun Shin MD. Professor of Medicine Division of Cardiology, Heart Center, Gil Medical Center Gacheon Medical School Incheon,
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationSubclavian and Vertebral Artery Angioplasty - Vertebro-basilar Insufficiency: Clinical Aspects and Diagnosis
HOSPITAL CHRONICLES 2008, 3(3): 136 140 ORIGINAL ARTICLE Subclavian and Vertebral Artery Angioplasty - Vertebro-basilar Insufficiency: Clinical Aspects and Diagnosis Antonios Polydorou, MD Hemodynamic
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationCarlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena
Which carotid procedures are required to grade the stroke risk? Carlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena Faculty disclosure Carlo Setacci I have no financial
More informationCarotid Revascularization
Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical
More informationJ ENDOVASC THER 2012;19:
303 CLINICAL INVESTIGATION Safety and Feasibility of Intravascular Optical Coherence Tomography Using a Nonocclusive Technique to Evaluate Carotid Plaques Before and After Stent Deployment Carlo Setacci,
More informationCerebral hyperperfusion syndrome after carotid angioplasty
case report Cerebral hyperperfusion syndrome after carotid angioplasty Zoran Miloševič 1, Bojana Žvan 2, Marjan Zaletel 2, Miloš Šurlan 1 1 Institute of Radiology, 2 University Neurology Clinic, University
More informationA Case of Unusual Presentation of Contrast-induced Encephalopathy after Cerebral Angiography Using Iodixanol
Journal of Cerebrovascular and Endovascular Neurosurgery pissn 2234-8565, eissn 2287-3139, http://dx.doi.org/10.7461/jcen.2017.19.3.184 Case Report A Case of Unusual Presentation of Contrast-induced Encephalopathy
More informationCase Report Cerebral Hyperperfusion Syndrome following Protected Carotid Artery Stenting
Case Reports in Vascular Medicine Volume 2013, Article ID 207602, 4 pages http://dx.doi.org/10.1155/2013/207602 Case Report Cerebral Hyperperfusion Syndrome following Protected Carotid Artery Stenting
More informationTasopoulou KM 1, Argyriou C 1, Mantatzis M 2, Kantartzi K 3, Passadakis P 3, Georgiadis GS 1
Tasopoulou KM 1, Argyriou C 1, Mantatzis M 2, Kantartzi K 3, Passadakis P 3, Georgiadis GS 1 1 Department of Vascular Surgery, 2 Department of Radiology/Interventional Radiology Unit and 3 Department of
More informationa. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).
12.0 Outcomes 12.1 Definitions 12.1.1 Neurologic Outcome Events a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)). Criteria:
More informationVivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine
Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither
More informationCarotid Artery Stenting
Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.
More informationCarotid Embolectomy and Endarterectomy for Symptomatic Complete Occlusion of the Carotid Artery as a Rescue Therapy in Acute Ischemic Stroke
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationCAROTID ARTERY ANGIOPLASTY
CAROTID ARTERY ANGIOPLASTY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and
More informationGUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY
GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY Full Title of Guideline: Author (include email and role): Guideline for Recovery Room Management of Patients after Carotid
More informationSAMMPRIS. Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis. Khalil Zahra, M.D
SAMMPRIS Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis Khalil Zahra, M.D Major points Patients with recent TIA or stroke and intra-cranial artery
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationSCAI Fall Fellows Course Subclavian/Innominate Case Presentation
SCAI Fall Fellows Course 2012 Subclavian/Innominate Case Presentation Daniel J. McCormick DO, FACC, FSCAI Director, Cardiovascular Interventional Therapy Pennsylvania Hospital University of Pennsylvania
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationSmall in-stent Low Density on CT Angiography after Carotid Artery Stenting
www.centauro.it Interventional Neuroradiology 14 (Suppl. 2): 41-46, 2008 Small in-stent Low Density on CT Angiography after Carotid Artery Stenting MIKA OKAHARA 1, HIRO KIYOSUE 2, JUNJI KASHIWAGI 1, SHINYA
More informationCerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11
Cerebrovascular Disorders Blood, Brain, and Energy 20% of body s oxygen usage No oxygen/glucose reserves Hypoxia - reduced oxygen Anoxia - Absence of oxygen supply Cell death can occur in as little as
More informationENDOVASCULAR THERAPIES FOR ACUTE STROKE
ENDOVASCULAR THERAPIES FOR ACUTE STROKE Cerebral Arteriogram Cerebral Anatomy Cerebral Anatomy Brain Imaging Acute Ischemic Stroke (AIS) Therapy Main goal is to restore blood flow and improve perfusion
More informationCurrent Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of November 19, 2018 Abdominal Aortogram, Bilateral Runoff
More informationRecanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion
Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Paul Hsien-Li Kao, MD Assistant Professor National Taiwan University Medical School and Hospital ICA stenting
More informationSubclavian Revascularization. Douglas E. Drachman, MD, FSCAI Division of Cardiology Vascular Medicine Section December 9, 2014
Subclavian Revascularization Douglas E. Drachman, MD, FSCAI Division of Cardiology Vascular Medicine Section December 9, 2014 Disclosure Information Douglas E. Drachman, MD, FACC Abbott Vascular, Inc.:
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationESM 1. Survey questionnaire sent to French GPs. Correct answers are in bold. Part 2: Clinical cases: (Good answer are in bold) Clinical Case 1:
ESM 1. Survey questionnaire sent to French GPs. Correct answers are in bold. Part 2: Clinical cases: (Good answer are in bold) Clinical Case 1: to your office at 2 pm for a feeling of weakness and numbness
More informationGuidelines for Ultrasound Surveillance
Guidelines for Ultrasound Surveillance Carotid & Lower Extremity by Ian Hamilton, Jr, MD, MBA, RPVI, FACS Corporate Medical Director BlueCross BlueShield of Tennessee guidelines for ultrasound surveillance
More informationPredictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis
Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Tadeusz Przewlocki, Anna Kablak Ziembicka, Piotr Pieniazek,
More informationThere are multiple endovascular options for treatment
Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationCORONARY ARTERY BYPASS GRAFT
CORONARY ARTERY BYPASS GRAFT Coronary artery disease develops because of hardening of the arteries (arteriosclerosis) that supply blood to the heart muscle. In the diagnosis of coronary artery disease,
More informationAn Expedient and Versatile Catheter for Primary STEMI Transradial Catheterization/Intervention
An Expedient and Versatile Catheter for Primary STEMI Transradial Catheterization/Intervention Jack P. Chen, MD, FACC, FSCAI, FCCP Medical Director, Northside Heart Institute, Atlanta, GA and Tak Kwan,
More informationCarotid Artery Stenting
Carotid Artery Stenting Natural history of the carotid stenosis Asymptomatic 80% carotid stenosis - 6% risk of stroke / year Symptomatic carotid stenosis have 10% risk of CVA at one year and 40% at 5 years
More information2017 Cardiology Survival Guide
2017 Cardiology Survival Guide Chapter 2: Angioplasty/Atherectomy/Stent The term angioplasty literally means "blood vessel repair." During an angioplasty procedure, the physician inserts a catheter, with
More informationA Case of Unilateral Posterior Reversible Encephalopathy Syndrome Occurring after Carotid Artery Stenting
Journal of Neuroendovascular Therapy 2017; 11: 403 408 Online April 17, 2017 DOI: 10.5797/jnet.cr.2016-0125 Osamu Kikuchi and Kenichi Ishizaki A Case of Unilateral Posterior Reversible Encephalopathy Syndrome
More informationIntra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage
Romanian Neurosurgery (2016) XXX 4: 461 466 461 DOI: 10.1515/romneu-2016-0074 Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage A. Chiriac, Georgiana Ion*,
More informationElective stenting of carotid artery stenosis in patients with severe coronary artery disease
European Heart Journal (1998) 19, 1365 1370 Article No. hj981048 Elective stenting of carotid artery stenosis in patients with severe coronary artery disease J. Waigand, C. M. Gross, F. Uhlich, J. Krämer,
More informationCorporate Medical Policy
Corporate Medical Policy Endovascular Therapies for Extracranial Vertebral Artery Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: endovascular_therapies_for_extracranial_vertebral_artery_disease
More informationRepair of Intracranial Vessel Perforation with Onyx-18 Using an Exovascular Retreating Catheter Technique
Repair of Intracranial Vessel Perforation with Onyx-18 Using an Exovascular Retreating Catheter Technique Michael Horowitz M.D. Pittsburgh, Pennsylvania Background Iatrogenic intraprocedural rupture rates
More information2019 ABBOTT REIMBURSEMENT GUIDE CMS Physician Fee Schedule
ABBOTT REIMBURSEMENT GUIDE CMS Physician Fee Schedule This document and the information contained herein is for general information purposes only and is not intended and does not constitute legal, reimbursement,
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationPRACTICE GUIDELINE. DEFINITIONS: Mild head injury: Glasgow Coma Scale* (GCS) score Moderate head injury: GCS 9-12 Severe head injury: GCS 3-8
PRACTICE GUIDELINE Effective Date: 9-1-2012 Manual Reference: Deaconess Trauma Services TITLE: TRAUMATIC BRAIN INJURY GUIDELINE OBJECTIVE: To provide practice management guidelines for traumatic brain
More informationNon Atheromatous Lesions Fibromuscular Dysplasia. Rod Samuelson, MD Babak Jahromi,, MD Elad Levy, MD Adnan Siddiqui,, PhD, MD Nick Hopkins, MD
Non Atheromatous Lesions Fibromuscular Dysplasia Rod Samuelson, MD Babak Jahromi,, MD Elad Levy, MD Adnan Siddiqui,, PhD, MD Nick Hopkins, MD Presenter Disclosure Information L. Nelson Hopkins MD FINANCIAL
More informationThe variation of carotid origin, the divergent orientation of common carotid (frequent posterior and left to right direction of right common as
1 Introduction The access to the common carotid during carotid stenting is very challenging and is responsible of a significant number of embolic complications in the ipsilateral but also in the contralateral
More informationCPT Code Details
CPT Code 93572 Details Code Descriptor Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically
More informationConcurrent Subarachnoid Hemorrhage and Acute Myocardial Infarction: A Case Report
Concurrent subarachnoid hemorrhage and AMI 155 Concurrent Subarachnoid Hemorrhage and Acute Myocardial Infarction: A Case Report Chen-Chuan Cheng 1, Wen-Shiann Wu 1, Chun-Yen Chiang 1, Tsuei-Yuang Huang
More informationAlan Barber. Professor of Clinical Neurology University of Auckland
Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal
More informationAdvances in the treatment of posterior cerebral circulation symptomatic disease
Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health
More informationAlgorithmic selection of emboli protection device during the procedure of carotid artery stunting
Algorithmic selection of emboli protection device during the procedure of carotid artery stunting Yasuhiro Kawabata, Tetsuya Tsukahara, Shunichi Fukuda, Tomokazu Aoki, Satoru Kawarazaki Department of Neurosurgery,
More informationCarotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery
2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1
More informationCHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION
CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION ARMANDO MANSILHA MD, PhD, FEBVS UNIVERSITY HOSPITAL - PORTO Disclosure of Interest Speaker name: ARMANDO MANSILHA I have the following potential conflicts
More informationRuptured aberrant internal carotid artery pseudoaneurysm presenting with spontaneous massive ear bleeding following a single sneeze: a case report
Case eport JNET 7:312-316, 2013 uptured aberrant internal carotid artery pseudoaneurysm presenting with spontaneous massive ear bleeding following a single sneeze: a case report Seiichiro HIONO 1) Eiichi
More informationIrretrievable unraveled coil remaining in the vascular lumen between the cerebral aneurysm and puncture site
Technical Note JNET 3:42-46, 2009 Irretrievable unraveled coil remaining in the vascular lumen between the cerebral aneurysm and puncture site Kouhei NII 1) Masanari ONIZUK 1) Yoshirou KNEKO 2) Hiroshi
More informationUpdate on Carotid Stenting. John R. Laird Cardiovascular Research Institute Washington Hospital Center
Update on Carotid Stenting John R. Laird Cardiovascular Research Institute Washington Hospital Center Carotid Stenting What a Crazy Idea! Pathogenesis of stroke Does it make sense to think that expansion
More informationRenal Artery Stenting With Embolic Protection
Renal Artery Stenting With Embolic Protection Embolic protection during renal stenting may be beneficial, but new device designs are necessary. BY RAJESH M. DAVE, MD Renal artery stenosis (RAS) is the
More informationChallenging of contrast agent-free endovascular treatment using 3D imaging
AC17-0010 Challenging of contrast agent-free endovascular treatment using 3D imaging Amane Kozuki Department of Cardiology, Osaka Saiseikai Nakatsu Hospital Introduction With advances in devices and techniques,
More information2013 Coding Changes. Diagnostic Radiology. Nuclear Medicine
2013 Coding Changes The principal coding changes affecting Radiologists in 2013 occur in the Interventional Radiology Section of the AMA/CPT Manual. As in the past, we continue to see the Relative Update
More informationFrom the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council
American Society of Neuroradiology What Is a Stroke? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair
More informationLimitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion
Carotid Stenting with Flow Reversal Marc Schermerhorn, MD Division of Vascular and Endovascular Surgery Beth Israel Deaconess Center Boston, MA Limitations of Other Embolic Protection Devices - Filters
More informationIntroduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9
Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...
More informationCoral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.
Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico
More informationDepartment of Internal Medicine, Saitama Citizens Medical Center, Saitama , Japan
Case Reports in Cardiology Volume 2016, Article ID 8790347, 5 pages http://dx.doi.org/10.1155/2016/8790347 Case Report GuideLiner Catheter Use for Percutaneous Intervention Involving Anomalous Origin of
More informationComparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)
Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
More informationPeripheral and Cardiology Coder 2018
Peripheral and Cardiology Coder 2018 Cardiovascular Services and Procedures Prepared and Published By: MedLearn Publishing A Division of MedLearn Media, Inc. 445 Minnesota Street, Suite 514 St. Paul, MN
More informationCAROTID ARTERY STENTING TECHNICALS ASPECTS. Symposium Abbott Vascular CANNES MEET 2008 Drs V PIRET, P BERGERON
CAROTID ARTERY STENTING TECHNICALS ASPECTS Symposium Abbott Vascular CANNES MEET 2008 Drs V PIRET, P BERGERON POINTS TO DISCUSS TO CAS INDICATIONS CONTRA INDICATIONS ANATOMICAL CONSIDERATION TECHNICS CAS
More information- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique?
- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique? Un chirurgien E. DUCASSE (Bordeaux) Un interventionnel
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of June 4, 2018 Thrombolysis, Thrombectomy & Angioplasty
More informationUpdated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary
SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b
More informationOverview of Subclavian & Innominate Artery Interventions
TCT 2016 Washington, DC, USA Tuesday November 1st, 2016 Peripheral vascular interventions Overview of Subclavian & Innominate Artery Interventions Dr Jacques Busquet Vascular & Endovascular Surgery Paris,
More informationDrug-Eluting Balloon Angioplasty for Carotid In-Stent Restenosis
J ENDOVASC THER 2012;19:729 733 729 CASE REPORT Drug-Eluting Balloon Angioplasty for Carotid In-Stent Restenosis Francesco Liistro, MD 1 ; Italo Porto, MD, PhD 1 ; Simone Grotti, MD 1 ; Giorgio Ventoruzzo,
More informationPost-op Carotid Complications A Nursing Perspective of What to Watch Out for
Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the
More informationCoronary angiography and PCI
Coronary arteries Coronary angiography and PCI Samo Granda, Franjo Naji Department of Cardiology Clinical department of internal medicine University clinical centre Maribor Coronary arteries Atherosclerosis
More informationAortic arch pathology. Cerebral ischemia following carotid artery stenosis.
Important: -Subclavian Steal Syndrome -Cerebral ischemia Aortic arch pathology. Cerebral ischemia following carotid artery stenosis. Mina Aubeed & Alba Hernández Pinilla Aortic arch pathology Common arch
More informationPercutaneous Transluminal Angioplasty and Stenting for Chronic Total Occlusion of Intracranial Carotid Artery A Case Report
www.centauro.it Interventional Neuroradiology 12: 263-268, 2006 Percutaneous Transluminal Angioplasty and Stenting for Chronic Total Occlusion of Intracranial Carotid Artery A Case Report H. ISHIHARA,
More informationHidden coronary disease in carotid patients
6 th ACST-2 Collaborators Meeting in Valencia, Spain 24th and 25th September 2018 Hidden coronary disease in carotid patients Valerio Tolva Policlinico di Monza Italy Are we always aware of coronary anatomy?
More informationINSTITUTE OF NEUROSURGERY & DEPARTMENT OF PICU
CEREBRAL BYPASS An Innovative Treatment for Arteritis INSTITUTE OF NEUROSURGERY & DEPARTMENT OF PICU CASE 1 q 1 year old girl -recurrent seizure, right side limb weakness, excessive cry and irritability.
More informationNicolas Bianchi M.D. May 15th, 2012
Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the
More informationPFO Management update
PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO
More informationNCDR CARE Registry Carotid Artery Revascularization and Endarterectomy Registry Carotid Artery Stenting Form v1.09
NCDR CARE Registry Carotid Artery Revascularization and Endarterectomy Registry Carotid Artery Stenting Fm v1.09 A. PARTICIPANT ADMINISTRATION Participant ID 1000 : Participant Name 1010 : Medicare Provider
More informationVascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)
Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Definition Vascular surgery is the specialty concerned with the diagnosis and management of congenital and acquired diseases of the
More informationCerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009
Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading
More informationTIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012
Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management
More informationMEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist
MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans DISCLOSURE Nothing Nothing to
More informationTreatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery
Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation
More informationCarotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA
Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:
More informationAndrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth. May 23, 2018
Andrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth May 23, 2018 Disclosure No personal financial relationships with any company. Presentation Outline Definitions, signs
More informationDiagnostic & Therapeutic Cardiac Catheterization Coder 2017
Diagnostic & Therapeutic Cardiac Catheterization Coder 2017 Including peripheral and cardiovascular services and procedures Prepared and Published By: MedLearn Publishing A Division of Panacea Healthcare
More informationBrain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage
Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University
More information